SCHEMBL24675626

SCHEMBL24675626

C[C@H](N)c1cccc(OCCCCCOCCCOCC(=O)O)c1

nearest known ligand 0.49

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ LMNA P02545 2/20 0.49
▸ KDM4E B2RXH2 1/20 0.49
▸ ALDH1A1 P00352 1/20 0.49
▸ CYSLTR2 Q9NS75 3/20 0.48
▸ CYSLTR1 Q9Y271 3/20 0.48
▸ PLA2G4B P0C869 3/20 0.47
▸ KMT2A Q03164 2/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ HRH3 Q9Y5N1 1/20 0.42
▸ PPARG P37231 2/20 0.42
▸ PPARD Q03181 1/20 0.42
▸ PTGES O14684 1/20 0.42
▸ ALOX5 P09917 1/20 0.42
▸ PPARA Q07869 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24675627 1.00 SMN1; SMN2 (0.49) SMN1; SMN2LMNAKDM4EALDH1A1CYSLTR2
SCHEMBL24675467 1.00 SMN1; SMN2 (0.49) SMN1; SMN2LMNAKDM4EALDH1A1CYSLTR2
SCHEMBL24675798 0.88 KDM4E (0.45) SMN1; SMN2LMNAKDM4EALDH1A1CYSLTR2
SCHEMBL24675470 0.88 KDM4E (0.45) SMN1; SMN2LMNAKDM4EALDH1A1CYSLTR2
SCHEMBL24675471 0.88 KDM4E (0.45) SMN1; SMN2LMNAKDM4EALDH1A1CYSLTR2
SCHEMBL24675791 0.88 CYSLTR2 (0.54) SMN1; SMN2LMNAKDM4EALDH1A1CYSLTR2
SCHEMBL24675410 0.88 CYSLTR2 (0.54) SMN1; SMN2LMNAKDM4EALDH1A1CYSLTR2
SCHEMBL24675240 0.88 CYSLTR2 (0.54) SMN1; SMN2LMNAKDM4EALDH1A1CYSLTR2
SCHEMBL24675411 0.88 CYSLTR2 (0.54) SMN1; SMN2LMNAKDM4EALDH1A1CYSLTR2
SCHEMBL24675644 0.85 PLA2G4B (0.48) LMNAALDH1A1PLA2G4BKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022159688-A9 DEGRADERS OF GRK2 AND USES THEREOF SONATA THERAPEUTICS, INC. (US) 2023-09-21 — — WO disclosed
WO-2023129564-A1 DEGRADERS OF GRK2 AND USES THEREOF CYGNAL THERAPEUTICS, INC. (US) 2023-07-06 — — WO disclosed
WO-2022159688-A1 DEGRADERS OF GRK2 AND USES THEREOF CYGNAL THERAPEUTICS, INC. (US) 2022-07-28 — — WO disclosed
Send feedback